Enhance the management system of rheumatism and chronic diseases, and create a new situation in rheumatism and immunity

Beijing, October 19, 2021/PRNewswire/ - In order to promote the development of rheumatism and immunology, and optimize the management of patients with rheumatism and immunity, well-known experts and scholars from the field of rheumatism and immunity, as well as medical workers in related disciplines, gathered together to discuss more This is a rheumatic disease management model and strategy, exchanges and shares new trends in rheumatic immune disease and chronic disease at home and abroad, in order to promote the innovation of rheumatic immune disease and chronic disease management model, strengthen regional exchanges and cooperation, and promote the construction of a chronic disease management system

Professor Liu Yi, Director of the Department of Rheumatology and Immunology, West China Hospital, Sichuan University, at the 2021 Annual Academic Conference of the Chronic Disease Management Group of the Rheumatology and Immunology Committee of the Cross-Strait Medical and Health Exchange Association and the 6th International Forum on Rheumatism Management on October 15 Said: "In recent years, many hospitals in various regions in China have improved their management of chronic diseases through the management of rheumatic diseases, and have achieved certain results.

To this end, with the support of Pfizer, the Chronic Disease Management Group of the Rheumatism and Immunology Special Committee of the Cross-Strait Medical and Health Exchange Association issued the proposal of "Strengthening the Management of Rheumatism and Immunology and Chronic Disease in China".

"Rheumatic immune disease is a serious chronic disease with complex etiology and long course of disease, which often leads to body dysfunction, which is called'undead cancer'

When talking about chronic disease management, Professor Yang Jing, director of the Department of Rheumatology and Immunology, Mianyang Central Hospital, emphasized: “The management of chronic disease of rheumatism and immunity refers to the organization of multidisciplinary personnel, such as specialist doctors, nurses, pharmacists, and rehabilitation.

As a corporate representative who has accumulated rich experience in multiple therapeutic fields, Dr.

Source: Pfizer